EHMT1


Summary: The protein encoded by this gene is a histone methyltransferase that methylates the lysine-9 position of histone H3. This action marks the genomic region packaged with these methylated histones for transcriptional repression. This protein may be involved in the silencing of MYC- and E2F-responsive genes and therefore could play a role in the G0/G1 cell cycle transition. Defects in this gene are a cause of chromosome 9q subtelomeric deletion syndrome (9q-syndrome, also known as Kleefstra syndrome). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in EHMT1


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IPI GO:0002039 p53 binding
MF IPI GO:0005515 protein binding
MF IDA GO:0008168 methyltransferase activity
MF IEA GO:0008270 zinc ion binding
MF IDA GO:0016279 protein-lysine N-methyltransferase activity
MF IDA GO:0018024 histone-lysine N-methyltransferase activity
Showing 1 to 6 of 28 rows rows per page

Gene expression in normal tissue: EHMT1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in EHMT1


Loading, please wait...
Database
Pathway ID
Pathway Des.
wikipathways WP2002 miR-targeted genes in epithelium - TarBase
wikipathways WP2004 miR-targeted genes in lymphocytes - TarBase
wikipathways WP2005 miR-targeted genes in muscle cell - TarBase
wikipathways WP2369 Histone Modifications
kegg hsa00310 Lysine degradation - Homo sapiens (human)
kegg hsa04211 Longevity regulating pathway - Homo sapiens (human)
Showing 1 to 6 of 20 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in EHMT1

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​